pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-378g |
Genomic Coordinates | chr1: 94745860 - 94745900 |
Description | Homo sapiens miR-378g stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-378g |
Sequence | 2| ACUGGGCUUGGAGUCAGAAG |21 |
Evidence | Experimental |
Experiments | Illumina |
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MRI1 | ||||||||||||||||||||
Synonyms | M1Pi, MRDI, MTNA, Ypr118w | ||||||||||||||||||||
Description | methylthioribose-1-phosphate isomerase 1 | ||||||||||||||||||||
Transcript | NM_001031727 | ||||||||||||||||||||
Other Transcripts | NM_032285 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MRI1 | |||||||||||||||||||||
3'UTR of MRI1 (miRNA target sites are highlighted) |
>MRI1|NM_001031727|3'UTR 1 CCAACTCAGCTCTCCCTAGCCTGCCTCTCTAGGTTTTTCAATACATTTCTTGAATGGCTACCCAAAAGCTGACCGTCCAG 81 CCCCTGACCACACTTGTTCCTAGTGCAGGGAGCTCAGACAGGGCCTTCCATCTAGAGCCCAGCACCTAGAGCCAGGCTGC 161 CCAGATTCAAATCCTGACTCCGCCACTTTTCCCACTGTATGATCTTGGGCAAGTCACTTCACCTCTCTGTGCCTTGGTTT 241 CCTCATTTATAAAATGTGGATAACAGGCCGGGCGCAGTGGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCGAGGCAG 321 GTGGATCACAAGATCAGGAGATTGAGACCATCCTGGCTAACATGGTGAAACCCCATCTCTACTAAAAATACAAAAAATTA 401 GCCGGGTGTGGTGGTGGGCACCTGCAGTCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATGGCGTGAAACTGGGAGGCAG 481 AGCTTGCAGTGAGCCGAGATAGCGCCACTGCACTCCAGCCTGGGCAACAGAGCGAGACTCCGTCTCAAAAATAAATATAA 561 TTAATTAATTATTTAATTAAAAAAATAAAAAATAAATGTGGATAATACTAGTACCTCCCTCTTAAGGTCAGGGCTGGAGC 641 TAGGGTGACATCTCCAGGGCAGAATTTTAAGAGGACACCAAAAAAGCTCAGCAACCAAGATAAAAAATATTTTAAAGCAA 721 TATTTTGTTTTGGGTTTTTTTTTTTTGAGATCAAGTATCACTCGTTACCCAGGCTGGAATGTAGAGGCGAGATCTCAGCT 801 CACTGAAACCTGTGCCTCCCCGGTTCAAGCGATTCTCCTGCCACAGCCTCCTGAGTAGCTGGGATTACAGGCATGCGCCA 881 CCATGCCCAGCTAATTTTTCTATTTTTAGTAGAGACATGATTTCACCATGTTGGCCAGGCTGGTCTCGAACTCCTGACTC 961 AAATGATCCCCCTGCCTCAGCCTCCCAAAGTGCTGGGACTACAGGCATGAGCCACTGTGCCTGACCTTACAGCAGTATTT 1041 TTTAAAAATCAAAATTAATGCAAAAATCCATGATGAGGCCAGGCTTGGTGGCTCATGCCTGTAATTCCAGCACTTTGGGA 1121 GGATCCCTTGAGCCCAGGTGTTTGAGACCAGTTTGGGTAACATAGGAAGAGCTTGTCTCTACAAACAAAAATTTAAAAAC 1201 AATGAGCTGGGCATGGAACTCACACCTCTAGCCCCAGCTACTCAGGCTGAAGTGGGAGGATGGCTTGAGCCCAGGAGTTC 1281 AAGGATGCAGTGTGCTTTGATTGCACTACTGCACTTCACCCTAAGCAACAGAGTGAGACCCCATCTCTTTAAAAAAAAAA 1361 AAAAATCCATGATGAACAAAACAAGTATTTGTTTGAGACGGGGTCTCGCTCTGTCGCCCAGGCTGGAGTACAGTGGTGCC 1441 ATCTCAGCTCACTGCAACCTCCGCCTTCTGGGTTCAAGCGACTCTCCTGCCTCAGCCTCCCGAGTAGCTGGGATTACAGG 1521 AGCCTGGCACTATGCCTGGCTAATTTTTGTATTTTTATTGGAGACACCATGTTAGTCGTGGCTGGTCTCCAACTCCTGAC 1601 CTCGGGTGATCCGCGCCCCGCGGCCTCCGAAAGTGCTGGGATTACAAGCGTGAGCCACCGTGCCCGGCCTAAATAAAATT 1681 TTGAAGAGGCTAGAACCCCGCACTTGTGCCTTGAGCTTACTGACCTCAACACCCTGGTTCCACTAAAACTTTATTTACAA 1761 AATTATGCTGCCGGTCTGCAGGATGTAGTTTAACAATTTGATTATTTTGGATATTAAAATATTTTTTAAGTCTTGAAAAT 1841 ATTGTTTACTATTACCAAAGTTTTTGAACCTTCTTAAATTCTGTACCAGAGGTGAGTGCCACACCCTAACCTAGTCTGAG 1921 TTTTTATGTGTAAAGATCATAAAACGTTGTAAGTTTTCTAAAACACATAAGCTCTCAATAAACGTTAGCTTATCATTGTC 2001 AAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_032285 | 3UTR | GAGGAUGGCUUGAGCCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_001031727 | 3UTR | GGCUUGAGCCCAGGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_001031727 | 3UTR | CCCAGAUUCAAAUCCUGACUCCGCCACUUUUCCCACUGUAUGAUCUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000319545.8 | 3UTR | AUUCAAAUCCUGACUCCGCCACUUUUCCCACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
68 hsa-miR-378g Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT444739 | SMYD1 | SET and MYND domain containing 1 | 2 | 2 | ||||||||
MIRT456104 | VAV3 | vav guanine nucleotide exchange factor 3 | 2 | 4 | ||||||||
MIRT458683 | MRI1 | methylthioribose-1-phosphate isomerase 1 | 2 | 2 | ||||||||
MIRT465802 | TMEM91 | transmembrane protein 91 | 2 | 2 | ||||||||
MIRT470843 | PLXND1 | plexin D1 | 2 | 2 | ||||||||
MIRT497263 | GRK6 | G protein-coupled receptor kinase 6 | 2 | 2 | ||||||||
MIRT497674 | SYNGR1 | synaptogyrin 1 | 2 | 2 | ||||||||
MIRT498218 | TLN2 | talin 2 | 2 | 2 | ||||||||
MIRT498309 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 2 | ||||||||
MIRT504046 | TOMM5 | translocase of outer mitochondrial membrane 5 | 2 | 2 | ||||||||
MIRT518196 | CLEC4E | C-type lectin domain family 4 member E | 2 | 2 | ||||||||
MIRT533143 | WNT10A | Wnt family member 10A | 2 | 2 | ||||||||
MIRT533540 | TPR | translocated promoter region, nuclear basket protein | 2 | 2 | ||||||||
MIRT533679 | TMEM86A | transmembrane protein 86A | 2 | 2 | ||||||||
MIRT540892 | SRSF9 | serine and arginine rich splicing factor 9 | 2 | 2 | ||||||||
MIRT541329 | G3BP1 | G3BP stress granule assembly factor 1 | 2 | 2 | ||||||||
MIRT541850 | PLIN5 | perilipin 5 | 2 | 2 | ||||||||
MIRT551431 | F2 | coagulation factor II, thrombin | 2 | 2 | ||||||||
MIRT552105 | PPP1R1A | protein phosphatase 1 regulatory inhibitor subunit 1A | 2 | 2 | ||||||||
MIRT564912 | YTHDF1 | YTH N6-methyladenosine RNA binding protein 1 | 2 | 2 | ||||||||
MIRT568605 | ACVR2A | activin A receptor type 2A | 2 | 2 | ||||||||
MIRT572604 | PAPLN | papilin, proteoglycan like sulfated glycoprotein | 2 | 2 | ||||||||
MIRT574234 | DMRT2 | doublesex and mab-3 related transcription factor 2 | 2 | 2 | ||||||||
MIRT575688 | Map1b | microtubule-associated protein 1B | 2 | 2 | ||||||||
MIRT576643 | Mill2 | MHC I like leukocyte 2 | 1 | 1 | ||||||||
MIRT609877 | RAD54L2 | RAD54 like 2 | 2 | 4 | ||||||||
MIRT610057 | MYBPC1 | myosin binding protein C, slow type | 2 | 2 | ||||||||
MIRT610791 | KLK2 | kallikrein related peptidase 2 | 2 | 2 | ||||||||
MIRT617175 | GOSR2 | golgi SNAP receptor complex member 2 | 2 | 2 | ||||||||
MIRT617707 | RUSC2 | RUN and SH3 domain containing 2 | 2 | 2 | ||||||||
MIRT620577 | WBSCR27 | methyltransferase like 27 | 2 | 4 | ||||||||
MIRT622657 | POU2F3 | POU class 2 homeobox 3 | 2 | 4 | ||||||||
MIRT624561 | BDP1 | B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB | 2 | 2 | ||||||||
MIRT634255 | TIAL1 | TIA1 cytotoxic granule associated RNA binding protein like 1 | 2 | 2 | ||||||||
MIRT634677 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT635254 | FBXL20 | F-box and leucine rich repeat protein 20 | 2 | 2 | ||||||||
MIRT637081 | SELPLG | selectin P ligand | 2 | 2 | ||||||||
MIRT639021 | AAK1 | AP2 associated kinase 1 | 2 | 2 | ||||||||
MIRT640396 | ZNF785 | zinc finger protein 785 | 2 | 2 | ||||||||
MIRT642441 | CLUAP1 | clusterin associated protein 1 | 2 | 2 | ||||||||
MIRT645666 | ADK | adenosine kinase | 2 | 2 | ||||||||
MIRT646083 | MGST3 | microsomal glutathione S-transferase 3 | 2 | 2 | ||||||||
MIRT650513 | UFM1 | ubiquitin fold modifier 1 | 2 | 2 | ||||||||
MIRT652474 | TMEM181 | transmembrane protein 181 | 2 | 2 | ||||||||
MIRT652584 | TIMM8A | translocase of inner mitochondrial membrane 8A | 2 | 2 | ||||||||
MIRT654763 | PRKAR2A | protein kinase cAMP-dependent type II regulatory subunit alpha | 2 | 2 | ||||||||
MIRT655200 | PHAX | phosphorylated adaptor for RNA export | 2 | 2 | ||||||||
MIRT658353 | FAM65B | RHO family interacting cell polarization regulator 2 | 2 | 2 | ||||||||
MIRT661820 | PRPSAP1 | phosphoribosyl pyrophosphate synthetase associated protein 1 | 2 | 2 | ||||||||
MIRT662190 | MEI1 | meiotic double-stranded break formation protein 1 | 2 | 2 | ||||||||
MIRT664375 | CYB5A | cytochrome b5 type A | 2 | 2 | ||||||||
MIRT665025 | ELK1 | ELK1, ETS transcription factor | 2 | 2 | ||||||||
MIRT666492 | SBNO1 | strawberry notch homolog 1 | 2 | 2 | ||||||||
MIRT668480 | EXOSC2 | exosome component 2 | 2 | 2 | ||||||||
MIRT682768 | TMEM120B | transmembrane protein 120B | 2 | 2 | ||||||||
MIRT689628 | NAA30 | N(alpha)-acetyltransferase 30, NatC catalytic subunit | 2 | 2 | ||||||||
MIRT691846 | OSCAR | osteoclast associated, immunoglobulin-like receptor | 2 | 2 | ||||||||
MIRT696490 | COX6B1 | cytochrome c oxidase subunit 6B1 | 2 | 2 | ||||||||
MIRT712480 | FSTL3 | follistatin like 3 | 2 | 2 | ||||||||
MIRT712780 | ZNF154 | zinc finger protein 154 | 2 | 2 | ||||||||
MIRT716607 | MPPED1 | metallophosphoesterase domain containing 1 | 2 | 2 | ||||||||
MIRT719357 | ITPKB | inositol-trisphosphate 3-kinase B | 2 | 2 | ||||||||
MIRT719739 | SLC39A11 | solute carrier family 39 member 11 | 2 | 2 | ||||||||
MIRT722569 | C1orf95 | stum, mechanosensory transduction mediator homolog | 2 | 2 | ||||||||
MIRT722838 | C17orf102 | chromosome 17 open reading frame 102 | 2 | 2 | ||||||||
MIRT733138 | LINC00963 | long intergenic non-protein coding RNA 963 | 3 | 0 | ||||||||
MIRT733139 | CHI3L1 | chitinase 3 like 1 | 3 | 0 | ||||||||
MIRT736944 | TARBP2 | TARBP2, RISC loading complex RNA binding subunit | 2 | 0 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|